YungpoBSuMD

Oncology • Omaha, NE

Physician

Join to view full profile

Dr. Su is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Su's full profile

Already have an account?

Office
7500 Mercy Rd
Ste 1300
Omaha, NE 68124
Phone+1 402-393-3110

Education & Training

NYU Grossman School of MedicineResidency, Internal Medicine, 1998 - 2001
New York University School of MedicineClass of 1998

Certifications & Licensure

NE State Medical License 2006 - 2026
IA State Medical License 2023 - 2025
NY State Medical License 1999 - 2006
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Start of enrollment: 2006 Oct 23
Completed
Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 2
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Active, not recruiting
Phase 2
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer Start of enrollment: 2020 Dec 09
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

47 citations
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
Matthew G. Fury, David B. Solit, Y. B. Su, Neal Rosen, Francis M. Sirotnak
Cancer Chemotherapy and Pharmacology. 2007-01-15
129 citations
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastri...
Manish A. Shah, Yelena Y. Janjigian, Ronald G. Stoller, Stephen Shibata, Margaret Kemeny
Journal of Clinical Oncology. 2015-11-20
8 citations
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz
The Lancet. Oncology. 2023-11-01